Companion animals in comparative oncology: One Medicine in action (Q91879123)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 27 August 2018

Language	Label	Description	Also known as
English	Companion animals in comparative oncology: One Medicine in action	scientific article published on 27 August 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Companion animals in comparative oncology: One Medicine in action (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

author name string

O A Garden

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

S W Volk

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

N J Mason

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

J A Perry

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

publication date

27 August 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

The Veterinary Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

240

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

6-13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Methods and mortality results of a health survey of purebred dogs in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Life span and cancer mortality in the beagle dog and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Naturally occurring cancers in dogs: insights for translational genetics and medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Malignant mammary tumor in female dogs: environmental contaminants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed-, gender-, age- and cause-specific rates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Use of indirect lymphography to identify sentinel lymph node in dogs: a pilot study in 30 tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Bruton's tyrosine kinase (BTK) inhibitors in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

PD-1 expression by canine T cells and functional effects of PD-1 blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Versican expression in myoepithelial cells from carcinomas in canine mixed mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Organohalogenated contaminants in domestic cats' plasma in relation to spontaneous acromegaly and type 2 diabetes mellitus: a clue for endocrine disruption in humans?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Epidemiologic study of relationships between consumption of commercial canned food and risk of hyperthyroidism in cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Mortality in over 350,000 insured Swedish dogs from 1995-2000: II. Breed-specific age and survival patterns and relative risk for causes of death

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Multidrug Analyses in Patients Distinguish Efficacious Cancer Agents Based on Both Tumor Cell Killing and Immunomodulation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Translating clinical trials from human to veterinary oncology and back

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Mesothelioma in pet dogs associated with exposure of their owners to asbestos

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Indirect computed tomography lymphangiography with aqueous contrast for evaluation of sentinel lymph nodes in dogs with tumors of the head.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Clinical development success rates for investigational drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Bladder cancer in pet dogs: a sentinel for environmental cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Toward a drug development path that targets metastatic progression in osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

The biology of Hepatocellular carcinoma: implications for genomic and immune therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Can the pharmaceutical industry reduce attrition rates?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

An immunohistochemical analysis of lymphocytic infiltrations in canine skin cancers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Triggering the landslide: The tumor-promotional effects of myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

A systematic review of localization, surgical treatment options, and outcome of insulinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

What's New in Old Horses? Postmortem Diagnoses in Mature and Aged Equids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Veterinary cancer epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Comparative Aspects of BRAF Mutations in Canine Cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Causes of death or reasons for euthanasia in military working dogs: 927 cases (1993-1996).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Tenascin expression in relation to stromal tumour cells in canine gastrointestinal epithelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Relationship between cell proliferation and tenascin-C expression in canine gastrointestinal tumours and normal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Expression of CD44 in canine mammary tumours.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Translation of new cancer treatments from pet dogs to humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Man's best friend becomes biology's best in show: genome analyses in the domestic dog

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

How to improve R&D productivity: the pharmaceutical industry's grand challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Hyperthyroidism in cats: what's causing this epidemic of thyroid disease and can we prevent it?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

A genome-based strategy uncovers frequent BRAF mutations in melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Regression of canine cutaneous histiocytoma is associated with an orchestrated expression of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Proteases as prognostic markers in human and canine cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Cancer immunotherapy in veterinary medicine: Current options and new developments

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Animal sentinels for environmental and public health

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

The importance of comparative oncology in translational medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Dynamic reciprocity in the wound microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Differential expression of CD44 in canine melanocytic tumours.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Pollutants in pet dogs: a model for environmental links to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

ASSESSMENT OF SENTINEL LYMPH NODE METASTASIS IN CANINE MAMMARY GLAND TUMORS USING COMPUTED TOMOGRAPHIC INDIRECT LYMPHOGRAPHY.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Heterologous expression and functional characterization of matrix metalloproteinase-11 from canine mammary tumor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Recruited leukocytes and local synthesis account for increased matrix metalloproteinase-9 activity in cerebrospinal fluid of dogs with central nervous system neoplasm

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Spontaneously occurring tumors of companion animals as models for human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Animals as sentinels of human health hazards of environmental chemicals

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Animal tumour registry of two provinces in northern Italy: incidence of spontaneous tumours in dogs and cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

DNA vaccine for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Cellular sources of tenascin-C in canine mammary carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2018.08.008

7 January 2021

Identifiers

10.1016/J.TVJL.2018.08.008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30268334%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q91879123&oldid=2204573208"